Proteomic and functional analyses of the virion transmembrane proteome of cyprinid herpesvirus 3 by Vancsok, Catherine et al.
Proteomic and Functional Analyses of
the Virion Transmembrane Proteome of
Cyprinid Herpesvirus 3
Catherine Vancsok,a M. Michelle D. Peñaranda,a V. Stalin Raj,a,b Baptiste Leroy,c
Joanna Jazowiecka-Rakus,a,d Maxime Boutier,a Yuan Gao,a Gavin S. Wilkie,e
Nicolás M. Suárez,e Ruddy Wattiez,c Laurent Gillet,a Andrew J. Davison,e
Alain F. C. Vanderplasschena
Immunology-Vaccinology, Department of Infectious and Parasitic Diseases, Fundamental and Applied
Research for Animals and Health, Faculty of Veterinary Medicine, University of Liège, Liège, Belgiuma; Indian
Institute of Science Education and Research Thiruvananthapuram, CET Campus, Thiruvananthapuram, Indiab;
Proteomic and Microbiology, Research Institute of Biosciences, University of Mons, Mons, Belgiumc; Maria
Sklodowska-Curie Institute, Oncology Center, Gliwice Branch, Gliwice, Polandd; MRC-University of Glasgow
Centre for Virus Research, Glasgow, United Kingdome
ABSTRACT Virion transmembrane proteins (VTPs) mediate key functions in the her-
pesvirus infectious cycle. Cyprinid herpesvirus 3 (CyHV-3) is the archetype of ﬁsh al-
loherpesviruses. The present study was devoted to CyHV-3 VTPs. Using mass spec-
trometry approaches, we identiﬁed 16 VTPs of the CyHV-3 FL strain. Mutagenesis
experiments demonstrated that eight of these proteins are essential for viral growth
in vitro (open reading frame 32 [ORF32], ORF59, ORF81, ORF83, ORF99, ORF106,
ORF115, and ORF131), and eight are nonessential (ORF25, ORF64, ORF65, ORF108,
ORF132, ORF136, ORF148, and ORF149). Among the nonessential proteins, deletion
of ORF25, ORF132, ORF136, ORF148, or ORF149 affects viral replication in vitro, and
deletion of ORF25, ORF64, ORF108, ORF132, or ORF149 impacts plaque size. Lack of
ORF148 or ORF25 causes attenuation in vivo to a minor or major extent, respectively.
The safety and efﬁcacy of a virus lacking ORF25 were compared to those of a previ-
ously described vaccine candidate deleted for ORF56 and ORF57 (Δ56-57). Using
quantitative PCR, we demonstrated that the ORF25 deleted virus infects ﬁsh through
skin infection and then spreads to internal organs as reported previously for the
wild-type parental virus and the Δ56-57 virus. However, compared to the parental
wild-type virus, the replication of the ORF25-deleted virus was reduced in intensity
and duration to levels similar to those observed for the Δ56-57 virus. Vaccination of
ﬁsh with a virus lacking ORF25 was safe but had low efﬁcacy at the doses tested.
This characterization of the virion transmembrane proteome of CyHV-3 provides a
ﬁrm basis for further research on alloherpesvirus VTPs.
IMPORTANCE Virion transmembrane proteins play key roles in the biology of her-
pesviruses. Cyprinid herpesvirus 3 (CyHV-3) is the archetype of ﬁsh alloherpesviruses
and the causative agent of major economic losses in common and koi carp world-
wide. In this study of the virion transmembrane proteome of CyHV-3, the major ﬁnd-
ings were: (i) the FL strain encodes 16 virion transmembrane proteins; (ii) eight of
these proteins are essential for viral growth in vitro; (iii) seven of the nonessential
proteins affect viral growth in vitro, and two affect virulence in vivo; and (iv) a mu-
tant lacking ORF25 is highly attenuated but induces moderate immune protection.
This study represents a major breakthrough in understanding the biology of CyHV-3
and will contribute to the development of prophylactic methods. It also provides a
ﬁrm basis for the further research on alloherpesvirus virion transmembrane proteins.
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Cyprinid herpesvirus 3 (CyHV-3; species Cyprinid herpesvirus 3, genus Cyprinivirus,family Alloherpesviridae, order Herpesvirales), also known as koi herpesvirus (KHV), is
the etiological agent of a lethal disease in common and koi carp. The common carp
(Cyprinus carpio) is one of the main ﬁsh grown for human consumption (1). Moreover,
its colorful ornamental varieties (koi carp) represent one of the most lucrative markets
for individual freshwater ﬁsh (2, 3). As a result, CyHV-3 is considered to be the
archetypal ﬁsh herpesvirus and is the subject of a growing number of studies (4).
The CyHV-3 genome is 295 kbp in size and thus the largest described among all
herpesviruses (5). It encodes 155 potential protein-coding open reading frames (ORFs),
a large number of which lack similarity to other herpesvirus genes (5–7). Nonetheless,
CyHV-3 virions present the characteristic herpesvirus morphology (8), consisting of an
icosahedral capsid containing the genome surrounded by an amorphous layer of
proteins termed the tegument and enveloped in a lipid membrane bearing virion
transmembrane proteins (VTPs) (8).
The protein composition of CyHV-3 virions has been investigated bymass spectrometry-
based proteomic approaches for one European and two Chinese strains (9, 10). These
analyses led to the identiﬁcation of 46 virion proteins, of which 34 were detected in all
three strains. Among these 34 proteins, 13 were classiﬁed as VTPs (9, 10). Since none of
these proteins are related to viral proteins with known roles, it is not possible to predict
their functions.
VTPs mediate key functions in the herpesvirus infectious cycle, such as binding
virions to the cell and mediating entry, providing immune evasion mechanisms,
facilitating virion morphogenesis, and promoting virion egress from the host cell. The
expression of VTPs on the virion surface may also make them targets for neutralizing
antibodies. As a result, it is important to study VTPs in order to understand the biology
of infection and to aid in the design of candidate vaccines (attenuated, nonreplicative,
or subunit). However, current knowledge of CyHV-3 VTPs is very limited. For example,
it is not known whether any of the VTPs identiﬁed to date are required for viral
replication in vitro.
Here, we performed proteomic and functional analyses of CyHV-3 VTPs. The pro-
teome of CyHV-3 virions was revisited. Based on this new information and that
published previously (9, 10), 16 VTPs were identiﬁed and selected for further study.
Using recombination technologies, VTPs that are essential to viral growth in vitro were
identiﬁed. Furthermore, the effects of deleting nonessential VTPs on viral growth in
vitro and virulence in vivo were investigated. The knowledge gained represents a major
breakthrough in understanding the biology of CyHV-3 and provides a ﬁrm basis for
further research on alloherpesvirus VTPs.
RESULTS AND DISCUSSION
Viral protein composition of CyHV-3 virions. We took advantage of the experi-
ence gained during our previous studies of the virion proteomes of herpesviruses (9,
11–13) to revisit the protein composition of extracellular CyHV-3 virions reported by us
and others (9, 10). We selected a strategy based on SDS-PAGE separation of proteins,
followed by liquid chromatography-tandem mass spectrometry (LC-MS/MS) of tryptic
peptides, because this approach has been shown to enhance the recovery of peptides
derived from proteins that are prone to aggregation or contain hydrophobic domains
(9, 11–13). The data listed in Table 1 represent independent analyses of three inde-
pendent preparations of CyHV-3 virions. A total of 43 viral proteins were identiﬁed
(based on detection in at least two of the preparations; Table 1 and Fig. 1). This number
is identical to that determined by Yi et al. (10). Comparison of the proteomes derived
from both studies revealed 39 proteins in common, with four proteins in each study
that were not identiﬁed in the other (Fig. 1).
Yi et al. (10) identiﬁed ORF11, ORF27, ORF91, and ORF116 as potential virion
proteins, whereas we did not. The lack of detection of ORF27 in our study was
anticipated because this coding region is disrupted in the FL strain, as has been
reported for other CyHV-3 strains (5). ORF91 and ORF116 were not detected in any of
Vancsok et al. Journal of Virology
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the preparations in the present study, and were identiﬁed by Yi et al. (10) for only one
of the two Chinese strains, with detection being based on a single peptide that was
supported by a low Mascot score (10). Similarly, ORF11 was detected on the basis of
only one or two peptides (depending on the isolate) with relatively low Mascot scores.
Among the four proteins that were detected in the present study and not by Yi et al.
(10), two were detected in all three replicates (ORF4 and ORF64), and the two other
were detected in only two replicates (ORF119 and ORF125). Finally, three proteins
identiﬁed in our previous study were detected neither by Yi et al. (10) nor in the present
study. Taking into account that these proteins were detected initially at relatively low
abundances (9), it is likely that they represented contamination by nonstructural
proteins.
In the context of the published bioinformatic analyses of the CyHV-3 genome (5, 6),
the results presented above suggest that the FL strain of CyHV-3 encodes 16 predicted
VTPs: ORF25, ORF32, ORF59, ORF64, ORF65, ORF81, ORF83, ORF99, ORF106, ORF108,
ORF115, ORF131, ORF132, ORF136, ORF148, and ORF149.
CyHV-3 VTPs essential to viral growth in vitro. The roles of CyHV-3 VTPs in viral
replication in vitro were investigated by using bacterial artiﬁcial chromosome (BAC)
cloning and prokaryotic recombination technologies to generate viral mutants (Fig. 2).
To facilitate the reconstitution of infectious viruses from recombinant plasmids, the BAC
cassette was left in the viral genome leading to viruses expressing a truncated form of
thymidine kinase (TK; encoded by ORF55) and enhanced green ﬂuorescent protein
(EGFP) (the BAC cassette is inserted at the 3= end of ORF55 and encodes an EGFP
expression cassette). The effect of TK truncation on viral replication in vitro and
virulence in vivo has been documented previously. TK truncation was shown to have no
effect on viral growth in vitro and to reduce virulence slightly in vivo (14). For each ORF
predicted to encode a VTP, a single-gene-deletion recombinant plasmid was produced
by replacing the ORF by a galK expression cassette. The molecular structures of all
recombinant BAC plasmids produced were conﬁrmed by a combined SacI digestion
and Southern blotting approach and by sequencing the regions used to target recom-
bination (data not shown). We then investigated the ability of the recombinant
plasmids to reconstitute infectious virus after transfection into permissive CCB cells (Fig.
3). Transfection was monitored by detecting EGFP-expressing cells (since the BAC
FIG 1 CyHV-3 virion proteome. Schematic representation of CyHV-3 virion-associated proteins identiﬁed
in independent studies: upper circle, analyses of the European FL strain performed in the present study;
lower left circle, analyses of the FL strain performed in a former study (9); and lower right circle, analyses
of two Chinese strains (GZ10 and GZ11) (10). Numbers represent CyHV-3 ORFs. Asterisks indicate viral
proteins that were detected in only one of the two Chinese isolates. Predicted transmembrane proteins
are underlined.
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cassette encodes an EGFP reporter gene) at 2 days postinfection (dpi). Examination of
cell cultures at 4 dpi revealed the formation of viral plaques for the FL BAC plasmid
(used as a positive control) and the BAC plasmids with ORF25, ORF64, ORF65, ORF108,
ORF132, ORF136, ORF148, or ORF149 deleted, thereby demonstrating that these ORFs
are nonessential for viral growth in vitro. Reconstituted viruses (i.e., viruses mutated in
nonessential genes) were ampliﬁed, and their genomes were validated by full-length
genome sequencing (data not shown) prior to further investigations (see below).
Transfection of BAC plasmids with ORF32, ORF59, ORF81, ORF83, ORF99, ORF106,
ORF115, or ORF131 deleted did not induce the formation of CyHV-3 plaques (Fig. 3),
suggesting that these ORFs encode VTPs essential for viral growth in vitro. To test this
hypothesis further, additional recombinant BAC plasmids were produced (Fig. 2). The
molecular structures of all recombinant BAC plasmids described below were conﬁrmed
by a combined SacI digestion and Southern blotting approach and by sequencing the
regions used to target recombination (data not shown). To exclude the possibility that
the lack of infectivity of the deleted recombinant BAC plasmids resulted from unex-
pected mutations generated during BAC manipulation, plasmids encoding revertant
wild-type (WT) VTP ORF were derived (FL BAC ORFX Rev1 plasmids, Fig. 2) from the
deleted BAC plasmids. Transfection of each of the revertant plasmids into CCB cells led
to viral growth (Fig. 4, second column). To exclude the possibility that the lack of
FIG 2 Production of CyHV-3 recombinants to identify essential and nonessential VTPs. Deleted recombinant
plasmids were produced for each ORF predicted to encode a VTP (FL BAC ORFX Del galK plasmids, with “X”
standing for the number of the ORFs tested; these included ORF25, ORF32, ORF59, ORF64, ORF65, ORF81, ORF83,
ORF99, ORF106, ORF108, ORF115, ORF131, ORF132, ORF136, ORF148, and ORF149). The effect of the deletion on
the ability of the BAC plasmid to reconstitute infectious virus was tested by transfection into permissive CCB cells.
Subsequently, for each gene identiﬁed as essential, two additional recombinant plasmids were produced to revert
to wild-type ORFX sequence (FL BAC ORFX Rev1) or to insert a nonsense mutation (FL BAC ORFX NS). Plasmids were
transfected into CCB cells to determine their ability to induce reconstitution of infectious virus. As an additional
revertant control, FL BAC ORFX NS plasmids were cotransfected into CCB cells together with a fragment encoding
the WT sequence of ORFX and ﬂanking regions, in order to facilitate reversion to wild-type ORFX sequence by
recombination in eukaryotic cells (FL BAC ORFX Rev2). To simplify the reading of the manuscript, some recombi-
nants were given a short name (in red). The right part of the Fig. summarizes the genotype of the strains for ORF55
(TK) and ORFX. Del, deleted; WT, wild type; BAC, presence of the BAC cassette in the 3= end of ORF55.
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infectivity observed for the deleted BAC plasmids resulted from a polar effect of the
deletion on the expression of a nearby essential gene, a recombinant plasmid in which
the ORF was disrupted by a nonsense (NS) mutation was derived for each putative
essential VTP gene (FL BAC ORFX NS plasmids, Fig. 2). Transfection of these plasmids
into CCB cells did not induce plaque formation (Fig. 4, third column). To exclude the
possibility that the lack of infectivity of the NS recombinant BAC plasmids resulted from
unexpected mutations generated during BAC manipulation at the stage of NS mu-
tagenesis, the FL BAC ORFX NS plasmids were transfected into CCB cells, together with
a WT DNA fragment containing the relevant ORF and ﬂanking regions, in order to
induce reversion to a WT sequence after homologous recombination in eukaryotic cells.
All plasmids led to viral growth when cotransfected with WT DNA fragments (Fig. 4,
fourth column). In summary, the results demonstrated that ORF32, ORF59, ORF81,
ORF83, ORF99, ORF106, ORF115, and ORF131 encode VTPs essential to viral growth in
vitro.
These experiments identiﬁed essential versus nonessential VTPs of the FL strain of
CyHV-3, as summarized in Table 2. To test whether the ﬁndings extend across the
species Cyprinid herpesvirus 3, the ORFs encoding VTPs were sequenced from nine
CyHV-3 strains with different geographical origins and passage histories (Table 2). All of
the ORFs encoding essential VTPs were intact and exhibited a limited number of
polymorphisms. In contrast, various ORFs encoding nonessential VTPs were truncated
by disruptive mutations (highlighted in red in Table 2), the precise pattern depending
on the strain.
FIG 3 Effect of deleting genes encoding VTPs on the ability of CyHV-3 FL BAC recombinant plasmids to
reconstitute infectious virus. CCB cells were transfected with the plasmids indicated. At 2 and 4 dpi, the
cells were examined by epiﬂuorescence microscopy (the BAC cassette encodes EGFP). Scale bar, 1 mm.
Plasmids able or not able to reconstitute infectious virus are labeled in green or red, respectively.
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Effects of deleting genes encoding nonessential VTPs on CyHV-3 growth in
vitro. Considerations of the CyHV-3 gene arrangement suggested that deletion of
ORF25, ORF64, ORF65, ORF108, ORF132, ORF136, or ORF148 would be unlikely to affect
the expression of neighboring genes. In contrast, deletion of ORF149 might affect the
expression of ORF148, resulting in the phenotype of TK BAC Δ149galK representing the
absence of expression of both proteins. To test this hypothesis, TK BAC Δ148galK and TK
BAC Δ149galK plaques were stained with monospeciﬁc polyclonal antibodies (pAbs)
against ORF148 or ORF149. Staining of TK BAC Δ149galK plaques with the anti-ORF148
antibodies demonstrated the expression of the ORF148 protein (data not shown),
implying that TK BAC Δ149galK is adequate for investigating the effects of deleting
ORF149.
The effect of deleting genes encoding nonessential VTPs on viral growth in vitro
was investigated by multistep growth assay (Fig. 5A) and plaque size assay (Fig. 5B).
Deletion of ORF25, ORF132, ORF136, ORF148, or ORF149 impaired CyHV-3 replication in
the multistep growth assays to various degrees (based on observation of a signiﬁcant
FIG 4 Testing plasmids recombinant for CyHV-3 ORFs predicted to encode essential VTPs. For ORFs
identiﬁed as essential in Fig. 3, additional recombinant plasmids (ORFX Rev1 and ORFX NS) were
produced (see Fig. 2, description in the rectangular frame) and tested for their ability to reconstitute
infectious virus after transfection into CCB permissive cells. At 6 days posttransfection, the cells were
examined by epiﬂuorescence microscopy for detection of EGFP. Scale bar, 1.5 mm.
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effect for at least two consecutive time points). The more pronounced effect was
observed for deletion of ORF25, which was associated with a 10-fold reduction in viral
titer. In contrast, deleting ORF64, ORF65, or ORF108 had no major effect on CyHV-3
growth. The plaque size assays (Fig. 5B), based on the results collected at 8 dpi, revealed
that deleting ORF25, ORF108, ORF132, or ORF149 resulted in reduced plaque size,
whereas deleting ORF64 led to an increased plaque size. Deleting ORF65, ORF136, or
ORF148 did not signiﬁcantly affect plaque size.
Effect of deleting genes encoding nonessential VTPs on CyHV-3 virulence in
vivo. All recombinant viruses deleted for a nonessential ORF (TK BAC ΔXgalK, where X
is the number of the ORF) were tested in triplicate for their virulence in carp (Fig. 6). Fish
infected with the TK BAC virus (used as a positive control) exhibited all the clinical signs
associated with CyHV-3 disease, including apathy, folding of the dorsal ﬁn, hyperemia,
increased mucus secretion, skin lesions, suffocation, erratic swimming, and loss of
equilibrium. At 30 dpi, the mean survival rate of TK BAC-infected ﬁsh was 41%. Fish
inoculated with TK BAC Δ64galK, TK BAC Δ65galK, TK BAC Δ108galK, TK BAC Δ132galK, TK
BAC Δ136galK, or TK BAC Δ149galK exhibited comparable effects, leading to similar
survival rates at 30 dpi (ranging between 33 and 56%). Conversely, ﬁsh infected with TK
BAC Δ148galK exhibited mild disease and a higher survival rate (77%, P  0.001). Fish
inoculated with TK BAC Δ25galK expressed no symptoms, and all survived the infection.
To ensure that each group of ﬁsh was infected with the correct virus and to exclude
any possibility of viruses spreading among the tanks, PCR assays were performed on
three randomly selected dead ﬁsh from each infected group (for TK BAC Δ25galK-
infected ﬁsh, three ﬁsh were selected randomly from the living ﬁsh at 30 dpi), one ﬁsh
infected with the TK BAC virus, and one mock-infected ﬁsh selected randomly at the
end of the experiment (Fig. 7). PCR performed with the ORF112intfw/ORF112intrev
primer pair conﬁrmed that samples from all but one group contained the CyHV-3
genome (the exception being the TK BAC Δ25galK-infected group). PCR performed with
primers speciﬁc for the deleted ORFs conﬁrmed that each group had been infected
TABLE 2 Polymorphisms observed among CyHV-3 strains in ORFs encoding VTPs
Gene Requirement in FL strain Mutationa
ORF32 Essential No mutation
ORF59 Essential No mutation
ORF81 Essential No mutation
ORF83 Essential Several aa inserted in M3, T, and J
ORF99 Essential Several aa changed in KHV-I, M3, T, and J
ORF106 Essential No mutation
ORF115 Essential One aa changed in T
ORF131 Essential One aa changed in KHV-I, FL, Cavoy, and T
ORF25 Nonessential Several aa inserted in M3, T, J, and GZ11
ORF27 Nonessential Frameshifted in U, KHV-I, T, and GZ11; large
regions deleted in FL; stop codon insertion
in the beginning of the ORF in Cavoy;
several aa changed in M3 and J
ORF64 Nonessential Frameshifted and several amino acids deleted
or inserted in M3, T, and J
ORF65 Nonessential One aa deleted in KHV-I, FL, Cavoy, I, and E; one
aa inserted and several aa deleted in M3, T,
and J; one aa changed in GZ11
ORF108 Nonessential One aa inserted, one aa changed and a stop
codon inserted at the end of the ORF,
several aa lost in M3, T, and J
ORF132 Nonessential One aa changed in KHV-I
ORF136 Nonessential Several aa inserted and a stop codon inserted
in the middle of the ORF in M3, T, and J
ORF148 Nonessential Several aa inserted in KHV-I, Cavoy, and GZ11;
Several aa deleted in M3, T, and J
ORF149 Nonessential One aa changed in KHV-I, Cavoy, and E, 13 aa
inserted in M3 and J
aBoldfacing indicates mutations that create an in-frame stop codon or frameshift. aa, amino acid(s).
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with the correct virus and that cross-contamination among tanks had not occurred
(Fig. 7).
Testing of an ORF25-deleted recombinant as an attenuated vaccine candidate
against CyHV-3. The attenuation described above for TK BAC Δ25galK, from which
ORF25 was deleted and encoding a truncated form of TK, suggested that a virus
deleted only for ORF25 would have potential as an attenuated recombinant vaccine
against CyHV-3. The requisite recombinant (Δ25galK, with ORF25 deleted and encoding
a wild-type TK) was produced by following the procedure described in Fig. 8 and in
Materials and Methods. The failure to detect virus by PCR in the gills of ﬁsh infected
with the TK BAC Δ25galK virus (Fig. 7) suggests that deletion of ORF25 could affect the
ability of deleted virions to infect ﬁsh or to spread within their host. To test this
hypothesis and to compare the tropism of a virus lacking ORF25 (Δ25galK) to the
tropism of a previously described recombinant vaccine candidate (deleted for ORF56
and ORF57, Δ56-57), the following experiment was performed. Fish were infected with
FIG 5 Effects of deleting nonessential VTPs on CyHV-3 growth in vitro. (A) Multistep growth curves. CCB
cells were infected with the viruses indicated and the titer (PFU/ml) in the cell supernatant was
determined at the indicated time points postinfection. Data presented are the means  the standard
errors of the mean (SEM) of triplicate measurements. Signiﬁcant differences between the deleted viruses
and the TK BAC virus were tested by using two-way ANOVA, taking genotype and time postinfection as
variables. (B) Plaque size assay. CCB cells were infected with the viruses indicated, and plaque areas were
measured over time. The data presented are means  the SEM for the measurement of 25 randomly
selected plaques. Two-way ANOVA was used to test the signiﬁcance of the results, taking genotype, time
postinfection, and interaction between genotype and time postinfection as variables (*, P  0.05; **, P 
0.01; ***, P  0.001).
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the FL BAC revertant virus (WT, wild-type for TK and for ORF25), FL BAC revertant ORF25
Del galK virus (Δ25galK, wild-type for TK but with ORF25 deleted), or the FL BAC
revertant ORF56-57 Del virus (Δ56-57, wild-type for TK but with ORF56-57 deleted) (Fig.
9). The viral charge was measured by qPCR over time in the skin (the portal of entry of
CyHV-3) and the heart (selected as an internal organ). The results demonstrated that
the ORF25 deleted virus infects ﬁsh through skin infection and then spreads to internal
organs as reported previously for the WT parental virus and the Δ56-57 virus (15).
FIG 6 Effect of deleting genes encoding nonessential VTPs on CyHV-3 virulence. The virulence of the
indicated recombinant viruses was tested in carp (triplicate groups each consisting of 15 subjects; average
weight, 1.90  0.68 g, and average age, 3 months old). On day 0, ﬁsh were infected for 2 h by immersion
in water containing 800 PFU/ml or mock infected. Survival rate was measured over a period of 30 days. The
nine upper panels show the survival curves observed for replicates. The lower panel shows the mean
survival curves based on the three replicates.
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However, compared to the parental WT virus, the replication of the ORF25 deleted virus
was reduced in intensity and duration to levels similar to those observed for the Δ56-57
virus.
Next, the virulence of the Δ25galK virus was compared to that of the WT strain and
the previously described Δ56-57 attenuated virus (Fig. 10) (15). A high degree of
attenuation of Δ25galK was indicated by the ﬁnding that infected ﬁsh exhibited no
mortality or symptoms (Fig. 10). The level of immune protection conferred by primary
infection with Δ25galK or Δ56-57 virus was tested by challenging infected ﬁsh with the
M3 or FL strains of CyHV-3 (Fig. 10, middle and lower lines of the graph, respectively).
The ﬁsh vaccinated with Δ25galK exhibited a poor level of protection, independent of
the dose used for primary infection and the challenge strain used, with the relative
percentage survival at a maximum of 34 when the ﬁsh were vaccinated at a dose of 400
PFU/ml and challenged with the M3 strain. In comparison, vaccination with the Δ56-57
attenuated virus resulted in a relative percentage survival of 84 under the same
conditions (Fig. 10).
The data above demonstrated that the VTP encoded by ORF25 is nonessential for
viral replication in vitro but acts as a key virulence factor in vivo. ORF25 is the
prototypical gene of the ORF25 family, which contains six paralogs (ORF25, ORF26,
ORF27, ORF65, ORF148, and ORF149) encoding type I transmembrane proteins (5).
FIG 7 PCR detection and characterization of CyHV-3 genomes recovered from infected dead carp. DNA
was extracted from the gills of three dead carp from each of the groups infected with the recombinant
viruses deleted for a nonessential gene (TK BAC ΔORFXgalK) during the course of the experiment
described in the legend of Fig. 6. In the TK BAC Δ25galK infections, no ﬁsh died, and hence three ﬁsh were
selected randomly from among the living ﬁsh at 30 dpi. A carp infected with TK BAC virus and a
mock-infected carp were used as positive and negative PCR controls, respectively. PCRs were performed
with the appropriate ORFXintfw/ORFXintrev primer pair and with the ORF112intfw/ORF112intrev primer
pair. The images are photographs of agarose gels. The numbers on the left of each panel are marker sizes
(bp). NC, negative control.
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Although ORF26 is a pseudogene, all other paralogs encode CyHV-3 VTPs. The FL strain
used in this study as the parental strain encodes a disrupted ORF27, as has been
reported for other strains of CyHV-3 (5). Individual deletions of each member of the
ORF25 family in this ORF27-negative background revealed that none of them is
essential for viral replication in vitro, although it is possible that this is the consequence
of redundant functions expressed by the paralogs. The attenuation observed for a
mutant lacking ORF25 suggested that this locus might serve as a target for generating
FIG 8 Flow chart of the production of CyHV-3 recombinants deleted for ORF25 or ORF56-57. Recombinants
were given a short name (in red) for use in the text. Viral genotypes for ORF55 (TK), ORF25, and ORF56-57
are given on the right. Del, deleted; WT, wild type.
FIG 9 Effect of ORF25 deletion on viral tropism according to qPCR analysis. At time zero, carp (average weight, 6.10 g 
1.39 g; average age, 6 months old) were infected for 2 h by immersion in water containing the virus indicated at 800
PFU/ml and then returned to larger tanks. At the indicated time points, ﬁsh were sampled and submitted to qPCR analysis.
The data obtained for each ﬁsh (according to viral genotype and time postinfection) are represented by the same symbol
to allow correlation of the data obtained for the two tested organs. The number of viral genome copies is expressed as
the log10 per 106 carp glucokinase gene copies. Individual values represent the mean of duplicate measurements.
Mock-infected ﬁsh were used as a negative control and no viral genome copies were detected in these ﬁsh. The number
of positive ﬁsh among six analyzed ﬁsh is represented by gray bars. Viral charges [viral genome copies/106 carp glucokinase
gene copies (log10)] were compared using one-way ANOVA taking the viral genotype as a variable.
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recombinant attenuated vaccines. However, there are two points of caution in relation
to this hypothesis: the ORF25 deletion virus induced weak immune protection, and it
is possible that reversion to virulence could occur by mutation of the paralogous genes.
Concluding remarks. Herpesvirus VTPs play crucial roles in the viral life cycle.
Although the functions of VTPs in members of the family Herpesviridae have been
studied extensively, very little information is available on VTPs in members of the family
Alloherpesviridae. The very distant evolutionary origin of these families has resulted in
a lack of detectable genetic similarity between VTPs in the two groups. This situation
makes it impossible to advance hypotheses on the roles of alloherpesvirus VTPs on the
basis of the much more extensive knowledge available for other herpesviruses. The
present study of the archetypal ﬁsh alloherpesvirus has enabled major steps to be taken
FIG 10 Testing of Δ25galK and Δ56-57 deletion recombinants as attenuated recombinant vaccine candidates. The virulence of the recombinant viruses indicated
was ﬁrst tested in carp (ﬁrst line of graph: four replicates per condition; n  20 ﬁsh; average weight, 2.42  0.95 g; average age, 6 months old). On day 0, ﬁsh
were mock infected or infected for 2 h by immersion in water containing 40 (dotted line) or 400 (continuous line) PFU of virus/ml. The survival rate was
measured over a period of 42 days. The immune protection conferred by primary infection was then tested for Δ25galK and Δ56-57-infected ﬁsh at 42 dpi by
distributing mock-infected ﬁsh and ﬁsh that survived the primary infection into duplicate tanks (n 20) and challenging them by cohabitation with ﬁsh infected
with the M3 strain (middle line of graphs) or the FL strain of CyHV-3 (lower line of graphs). The survival rate was measured according to time postchallenge.
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toward characterizing alloherpesvirus VTPs: (i) the number of CyHV-3 VTPs was ex-
panded from 14 to 16; (ii) these were characterized as consisting of eight essential and
nine nonessential proteins; (iii) individual deletion of seven nonessential VTPs affected
viral growth in vitro, and individual deletion of two affected virulence in vivo; and (iv)
a mutant lacking ORF25 proved to be highly attenuated in vivo but induced a poor
immune protection against a lethal challenge. This study provides a ﬁrm basis for the
further study of alloherpesvirus VTPs.
MATERIALS AND METHODS
Cells and viruses. Cyprinus carpio brain (CCB) cells (16) were cultured as described previously (14).
The CyHV-3 FL strain was isolated in Belgium from a ﬁsh that had died from CyHV-3 infection and had
been used to produce the FL BAC plasmid (14). Other CyHV-3 strains from different geographical origins
were also used: the M3 strain from Belgium, the U strain from the United States (5); the J strain from
Japan (5), the E strain from England (kindly provided by K. Way), the T strain from Taiwan (17), the GZ11
strain from China (18), and the KHV-I and I strains from Israel (5). The attenuated Cavoy strain from Israel
was produced by passaging in cell culture (19).
Production and puriﬁcation of CyHV-3 virions. CCB cells were infected with the CyHV-3 FL strain
at a multiplicity of infection (MOI) of 0.02 PFU/cell (20). The supernatant was harvested at the beginning
of viral release, when cell lysis was minimal (4 dpi). Virions were puriﬁed from the cell supernatant and
monitored for purity as described previously (9).
SDS-PAGE and LC-MS/MS proteomic analysis. Virion proteins were separated by SDS-PAGE and
detected by Coomassie blue staining. The entire lanes of the gel were cut into 30 equally sized slices,
which were subjected to in-gel trypsin digestion (21). Peptides were separated by reversed-phase
chromatography using a 40-min CAN gradient (4 to 45%) and analyzed by using an HCT ultra-ion trap
(Bruker) in data-dependent AutoMS (2) mode with a scan range of 100 to 2,800 m/z and three averages,
and ﬁve precursor ions at 300 to 1,500 m/z were selected from the MS scan. Precursors were actively
excluded within a 0.5 min window, and all singly charged ions were excluded. The MS data were
processed by using Mascot distiller, and all single-slice analyses were merged into a single data set. The
data were searched for matches to CyHV-3 protein sequences (160 entries) by using an in-house Mascot
2.2 server (Matrix Science). The default search parameters used were as follows: enzyme  trypsin,
maximum missed cleavages  1, ﬁxed modiﬁcations  carbamidomethyl (C), variable modiﬁcations 
oxidation (M), peptide tolerance  1.3 Da; MS/MS tolerance   0.5 Da, and instrument  ESI-TRAP.
Only sequences identiﬁed by a Mascot score of 30 were considered, and single peptide identiﬁcation
was systematically evaluated manually. In addition, the emPAI (22) value was calculated to estimate
relative protein abundance in the GC extract only.
Antibodies. Mouse pAbs against CyHV-3 ORF148 or ORF149 were produced by customized DNA
immunization (DelphiGenetics).
Cloning and site-directed mutagenesis of CyHV-3 ORFs. DNA fragments containing CyHV-3 ORFs
of interest plus at least 200 bp upstream and downstream were ampliﬁed by PCR using CyHV-3 FL BAC
DNA as a template (see Table 3 for primer details). The ampliﬁcation products were TA cloned into the
pGEM-T-Easy vector (Promega), and the resulting clones (pGEM-T-ORFX WT, X standing for the number
of the ORF tested) with the correct sequence were used as a recombination cassette or as a template for
mutagenesis. For ORFs encoding VTPs, site-directed mutagenesis was used to create 1- or 2-bp substi-
tutions changing a tyrosine or a tryptophan codon into a stop codon, resulting in pGEM-T-ORFX NS.
Oligonucleotide primers were designed by using the QuikChange primer design tool (http://www
.genomics.agilent.com/primerDesignProgram.jsp) (Table 3).
Production of CyHV-3 FL BAC recombinant plasmids and CyHV-3 recombinant viruses using
BAC cloning and prokaryotic recombination technologies. CyHV-3 FL BAC recombinant plasmids and
CyHV-3 recombinant viruses were produced on the basis of the strategy outlined in Fig. 2 and 8, by using
a two-step galactokinase gene (galK) positive/negative selection in bacteria (15, 23). Single-gene deleted
recombinant plasmids were produced for various ORFs by replacing the sequence (initiation codon to
stop codon) by a galK expression cassette (galK positive selection). Recombination cassettes encoding
galK were produced by PCR using the primers listed in Table 3 and the pgalK vector as the template. The
derived ORFX Del galK cassette consisted of the galK gene ﬂanked by 75-bp sequences homologous to
the regions of the CyHV-3 genome immediately upstream and downstream of ORFX. The ﬂanking
sequences served as targets to induce homologous recombination with the FL BAC parental plasmid in
competent E. coli cells, resulting in replacement of the entire ORF by the galK expression cassette (FL BAC
ORFX Del galK plasmid).
The recombinant FL BAC plasmids were transfected into permissive CCB cells in the presence of
polyethylenimine (PEI). Transfection of the BAC plasmids and eventual reconstitution of infectious virus
were monitored by epiﬂuorescence microscopy, since the FL BAC plasmids and derived viruses contained
an EGFP expression cassette. For mutations that did not prevent reconstitution of infectious virus (i.e., in
nonessential genes), cell supernatants were collected and the viruses were ampliﬁed, leading to FL BAC
recovered ORFX Del galK viruses. For mutations that prevented reconstitution of infectious virus (i.e., in
essential genes), further investigations were performed. For each ORF identiﬁed as being essential for
viral growth, WT revertant (Rev1) and nonsense (NS) mutation clones were produced by using a second
recombination process (galK negative selection). ORFX Rev1 and ORFX NS recombination cassettes
were produced by PCR using WT FL BAC DNA and pGEMT-ORFX NS as the templates, respectively (see
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TABLE 3 Oligonucleotide primersa
Analysis Primer Sequence (5=–3=)b
Coordinates or
accession no.
Synthesis of inserts
CyHV-3 ORF25 ORF25outF CCTCCGACTCTGAAGACGAT 45389–45408
ORF25outR GGTACGTGATGCTGTAGAAG 47569–47588
CyHV-3 ORF32 ORF32outF CCAGGTCCAGGCAGTCTC 54216–54233
ORF32outR ATGCGCGTCTACAAGATCG 55619–55601
CyHV-3 ORF59 ORF59outF GACGCCTGTCTCTGGTAGA 101541–101559
ORF59outR GCGTCTCCAAAAAGAGCGG 102941–102923
CyHV-3 ORF64 ORF64outF GTCGAGATATCCGAGGCAGA 119716–119735
ORF64outR TTCATAGCCACAACCGGAGT 122203–122184
CyHV-3 ORF65 ORF65outF TGGAGAACATCAAGCAGCAC 121920–121939
ORF65outR GAAGTCTGAAACTGTCTGAATG 124106–124127
CyHV-3 ORF81 ORF81outF GGTTTAGTCCAAATCCGACCT 150519–150539
ORF81outR GCAGCTTCTGCTTCAGAGTG 152023–152004
CyHV-3 ORF83 ORF83outF ACACGCTGATGGTCACGAG 152549–152567
ORF83outR ACACCAACCAGTTCGTGCAG 153638–153619
CyHV-3 ORF99 ORF99intF GCTTAGCCTGTTCGGCAC 184445–184462
ORF99intR AAGATCTGGGACACGGACTG 185515–185496
CyHV-3 ORF106 ORF106outF GCTGACACCTGTCACAACCA 195629–195648
ORF106outR TCGTGAGGACAAACCGTCTC 196189–196170
CyHV-3 ORF108 ORF108outF GATGATGAAGGGTGTTCATG 201067–201086
ORF108outR CATCTACAAGTCGGACAACC 201937–201956
CyHV-3 ORF115 ORF115outF CACGTAAACGAAGCCCCATA 207951–207970
ORF115outR ATTCGTGGCGGCTGTTATAC 210734–210715
CyHV-3 ORF131 ORF131outF GCCCTGGTCCTCGTACTTTT 224971–224990
ORF131outR CTGATCAGATTCTCAGGAGCAG 227271–227250
CyHV-3 ORF132 ORF132outF GCTCCTGAGAATCTGATCAG 227252–227271
ORF132outR GTTAATGGTCACAGAAGCGC 228155–228174
CyHV-3 ORF136 ORF136outF GTGTCAAGTACGTGGAGCGT 231157–231176
ORF136outR GGCCTCTGAATGTGTTATTGC 231991–232011
CyHV-3 ORF148 ORF148outF CATGGTTCGAGGTTGTGAAG 253808–253827
ORF148outR CAGCATTCGTCTCTTAGTGC 255933–255952
CyHV-3 ORF149 ORF149outF ACCCTATCATGATTGACGGC 255770–255789
ORF149outR CTTTCGTTCTACTGTTCCTC 258172–258191
Synthesis of galK
recombination
cassettes
ORF 25 Del galK ORF25 galK F GTCATTTTTCCTCGTGGTGTGCAGCTTTTTCTAACGTGTGGTAGGACGCTAACC
ATTACCAAGTAAACCATTACGCCTGTTGACAATTAATCATCGGCA
45495–45569
ORF25 galK R TGACCAGGGTAGAATGATAGACCCGCCGCTAAGAAAAATGACTCTCCGTCCGC
TACCGTCGCCCGCTATAGTGTTTCAGCACTGTCCTGCTCCTT
47376–47450
ORF 32 Del galK ORF32 galK F ATAATACGCACCCTGGTCACTTTCTTTAACGTGTCCGTGTCGGGCTCCCTACAC
GTTTCCTCCGAGTCGCCGATCCCTGTTGACAATTAATCATCGGCA
54417–54491
ORF32 galK R CTGTATCCCATCAGGGGCTGATCTGCTGACGGCCTCGACGTGGTGGTGATGGTG
GTGGTGGTGGTGATGATGATGTCAGCACTGTCCTGCTCCTT
54491–54417
ORF 59 Del galK ORF59 galK F CCCGCACGACGTCGGACGCTCCCTACCGAGTGAGCCGTCTCTCTGACCCGGGTC
GTGCGGGCGCCACCAGCCCTTCCTGTTGACAATTAATCATCGGCA
101961–102035
ORF59 galK R AGCAGTGGTAGTCCTCTCACCCCCCCCCCCCCCCCCTTGACCTTCACCCTTCAC
CCCTAACCCCAACAACCAACCTCAGCACTGTCCTGCTCCTT
102521–102447
ORF 64 Del galK ORF64 galK F TGGTCCTCCCATGCTTTTTATTCAATCCTGCTCCTCTTGAAAAGCTTAAG
CCTGTTGACAATTAATCATCGGCA
119814–119863
ORF64 galK R GTACACTATATTGCGTTTATTTGTTTTTCATAAAAAGCACATACATAATA
TCAGCACTGTCCTGCTCCTT
122082–122033
ORF 65 Del galK ORF65 galK F CAATATAGTGTACACCGTGGTCTTTATTAATTTGATAACATAATAATGTA
CCTGTTGACAATTAATCATCGGCA
122070–122119
ORF65 galK R CAAGACGCCTCACACGACGGAAACCCGCAACACCACCCCACAAACAAACG
TCAGCACTGTCCTGCTCCTT
123911–123960
ORF 81 Del galK ORF81 galK F GCACTTGAGAGCAGCGGAGGAGAAGACCGGTGCATCCATCTCGACGCTCGTCAGG
TTGTGACTGTCCTCGTCCTCCCTGTTGACAATTAATCATCGGCA
150722–150796
ORF81 galK R CGGCTGCTGTGTTTTGTGGTGCTGGCCTCGACTGTGGGGTGGTGGTGGCGGCG
ACTGCGAGAGGCTTCGGAATCAGCACTGTCCTGCTCCTT
150796–150722
ORF 83 Del galK ORF83 galK F CACAATAAAAAGCTCCCCTCGGGGATCACCAAGACAACCTTTCAGTAGCC
CCTGTTGACAATTAATCATCGGCA
153481–153530
ORF83 galK R TCTTCGCCCTCGCCCTCGTCCCTCAACCTGTTGTACCTATACGCGCTCAT
TCAGCACTGTCCTGCTCCTT
152758–152807
ORF 99 Del galK ORF99 galK F TGCAGGCCACCGCCGCCAACGCCGAGATGTCCAACAACCTCCAGACGCAG
CCTGTTGACAATTAATCATCGGCA
184714–184763
ORF99 galK R AGGGCTTGCTCTTGAGGAAGGGCTGGTTGACGGGGCAGCCCTGCAGGTAA
TCAGCACTGTCCTGCTCCTT
185214–185165
(Continued on next page)
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TABLE 3 (Continued)
Analysis Primer Sequence (5=–3=)b
Coordinates or
accession no.
ORF 106 Del galK ORF106 galK F ACTACTCGCCCACCGCCTTATACAACTTCACCGCGTATCCGCCGTACATC
CCTGTTGACAATTAATCATCGGCA
195727–195776
ORF106 galK R GGGTTTGGTAGAGGGCGCTGCGGGGGATGAGCCCGACGATACCGCTGCGG
TCAGCACTGTCCTGCTCCTT
196063–196014
ORF 108 Del galK ORF108 galK F CACTTAGTCTACCACTCACTTTACCTTACAACCACCCAGACACCAACACACCA
CACCACCCACACTACGAGCGAGCCTGTTGACAATTAATCATCGGCA
201156–201230
ORF108 galK R ACCAAGCAACACGTTCATGTGATTTTTTTTTATTGTTGATGTTGTTTGATGTA
TTACAGTTACAATAAACGTAATTCAGCACTGTCCTGCTCCTT
201819–201893
ORF 115 Del galK ORF115 galK F ATCGTGTCCTCCGTCTCGGTCATCTCTGTGGTTTTTTCCAGCTTTGCGCC
CCTGTTGACAATTAATCATCGGCA
208152–208226
ORF115 galK R GCTCAAAATAAAAAAAACATGTCTGGACCTTTACATCTTGTTTCAATAAT
TCAGCACTGTCCTGCTCCTT
210641–210567
ORF 131 Del galK ORF131 galK F GTGAGGGAGTGATATGGAGTGAACGTAAATGGAGGGGCGCTGCGGAGGTT
CCTGTTGACAATTAATCATCGGCA
225410–225484
ORf131 galK R TCGAGACGCCCGAACTGGTCGAGGCCTACGTGAACGACGTCAAGGTCCGC
TCAGCACTGTCCTGCTCCTT
226426–226352
ORF 132 Del galK ORF132 galK F TCAAGTCTTTATTATTACTTTATTTAATGGGGTTCGGTTGGAGAAGAGCAGTCA
AGTGAGCAGAAGAGAAGATCGCCTGTTGACAATTAATCATCGGCA
227369–227443
ORF132 galK R AACTGAGGCCTCTCCGGCTATCCGCACCGAGTGATATACCGCCCGCCACTACC
CCAGAACCCCCACACAGCCGCATCAGCACTGTCCTGCTCCTT
227957–228031
ORF 136 Del galK ORF136 galK F AAGCTTGCCTTTGAAACATGGAAAAGAGCTCTCGTGTGTTTCTTTAGAATAAG
ACGACGTCGAGCGACGACCATCCCTGTTGACAATTAATCATCGGCA
231264–231337
ORF136 galK R TGTTGGTTTGCTTTGGCTTGATAGCACACAAAAATCACATTTGTAAGAGTTTTATT
GTTTGACAATGATACATCATCAGCACTGTCCTGCTCCTT
231801–231875
ORF 148 Del galK ORF148 galK F GAGGGTAGAGAGGGCTGGAGAGTAGGAGAGGAGAGAGGGGAAAGTTTTGAAG
TTCTTGCACATGTTGAGGGGAAGCCTGTTGACAATTAATCATCGGCA
253881–253955
ORF148 galK R AAAACCAAAATTTTTCTGTTATCGTATCGTGATGAGCGCGACCGAGGCGACGGTCC
AGTAACTCCGCCGTCAATCTCAGCACTGTCCTGCTCCTT
255780–255854
ORF 149 Del galK ORF149 galK F TTTGCTTTTTTTATTATGTGATGCTGTAGTGTACACACGTATTAGAAACAATAGTA
GAGCAAGCAAGCAAAAGCCCTGTTGACAATTAATCATCGGCA
255861–255935
ORF149 galK R TTTTCTTTTGACGCGCAATGACCGACGGCTCAAGTGACGGCTACCTAGACGATACG
TCACAGACGGCTGAGGACCTCAGCACTGTCCTGCTCCTT
257997–258071
Nonsense mutagenesis of
essential genesc
ORF32 ORF32.T237G-sense GACAACGGCTGGGGCTAGACCTTTCTGATCCAATC 54711–54745
ORF32.A237C-antisense GATTGGATCAGAAAGGTCTAGCCCCAGCCGTTGTC 54745–54711
ORF59 ORF59.C144G-sense CATGCAGCGCTAGCAACTGTGCGAG 102315–102291
ORF59.G144C-antisense CTCGCACAGTTGCTAGCGCTGCATG 102291–102315
ORF81 ORF81.C207G-sense TTGCGCACGCCATGTAGTCCAACGATCCC 150987–151015
ORF81.G207C-antisense GGGATCGTTGGACTACATGGCGTGCGCAA 151015–150987
ORF83 ORF83.G225A-sense GTTCATGTACTGAGTCACCCTACGC 153268–153244
ORF83.C225T-antisense GCGTAGGGTGACTCAGTACATGAAC 153244–153268
ORF99 ORF99.C3039G-sense CAACGACAGGTTCTCGTAGGTGGCGAGCC 184946–184974
ORF99.G3039C-antisense GGCTCGCCACCTACGAGAACCTGTCGTTG 184974–184946
ORF106 ORF106.CA108AT-sense CTTCGTCGTCTAATAGGCCCAGCAC 195872–195896
ORF106GT108TA-antisense GTGCTGGGCCTATTAGACGACGAAG 195896–195872
ORF115 ORF115.C744A-sense GGACCTGGTCCTGTAATCCCAGACGAACGTG 208955–208985
ORF115.G744T-antisense CACGTTCGTCTGGGATTACAGGACCAGGTCC 208985–208955
ORF131 ORF131.C735G-sense TCCAGGGCCGTGTAGGAGGCCGC 226054–226032
SDM131.G735C-antisense GCGGCCTCCTACACGGCCCTGGA 226032–226054
Synthesis of probes for
Southern analysis
(probe name)
GalK GalK.Int2-F AGGTGAGGAACTAAACCCAG
GalK.Int2-R CGTATTGCAGCAGCTTTATC
ORF32 ORF32.SB-F CAGATGTGGCTGGACATGA 54567–54585
ORF32.SB-R GCTACCCAGGTGGTGTTGTT 55006–54987
ORF59 ORF59.SB-F GTTCTGCGTCGAGGATGATG 102042–102061
ORF59.SB-R CGTTCAGCACCTCGGTCTAC 102427–102408
ORF81 ORF81.SB-F AAAGCTCAACTGGCCAAGAG 150809–150828
ORF81.SB-R ACACCGCCGTCTTCGAGTAG 151259–151240
ORF83 ORF83.SB-F TGCTCTCCACGTCCTTGTA 152838–152856
ORF83.SB-R ATGTCTCCTTTGTGCGGTC 153480–153462
ORF99 ORF99.SB-F CCTCCAGACGCAGATCAACT 184751–184770
ORF99.SB-R CTTGAGGAAGGGCTGGTTG 185204–185186
ORF106 ORF106.SB-F GCAGCAGCAGCAGAAGTG 195783–195800
ORF106.SB-R TCAGTTGGTCTTGGGGCC 196013–195996
(Continued on next page)
CyHV-3 Virion Transmembrane Proteins Journal of Virology
November 2017 Volume 91 Issue 21 e01209-17 jvi.asm.org 17
 o
n
 O
ctober 25, 2017 by SW
ETS SUBSCRIPTIO
N SERVICE
http://jvi.asm.org/
D
ow
nloaded from
 
Table 3 for primers). The resulting FL BAC ORFX Rev1 and FL BAC ORF X NS plasmids were transfected
into CCB cells as described above. To exclude the possibility that the lack of infectivity of the NS-null
recombinant BAC plasmids was due to unexpected mutations during BAC manipulation, FL BAC ORFX NS
plasmids were also transfected into CCB cells together with a WT DNA fragment containing the
appropriate ORF and upstream and downstream ﬂanking regions, in order to induce reversion to a WT
sequence after homologous recombination in eukaryotic cells.
Genetic characterization of CyHV-3 recombinant BAC plasmids and derived recombinant
viruses. CyHV-3 FL BAC recombinant plasmids and derived recombinant viruses were characterized by
sequencing regions of interest and by assessing the sizes of SacI fragments by agarose gel electropho-
resis and Southern blotting (24). Probes for Southern blotting were produced by PCR using the primers
listed in Table 3. CyHV-3 recombinant viruses deleted for nonessential genes (the FL BAC recovered ORFX
Del galK viruses and the FL BAC revertant ORF25 Del galK virus) were characterized further by full-length
genome sequencing as described previously (15).
Indirect immunoﬂuorescence staining. Cells grown on glass coverslips were ﬁxed in phosphate-
buffered saline (PBS) containing 4% (wt/vol) paraformaldehyde at 4°C for 15 min and then 20°C for 10
min. After a washing step with PBS, samples were permeabilized in PBS containing 0.1% (vol/vol) NP-40
at 37°C for 15 min (15). Immunoﬂuorescence staining (incubation and washes) was performed in PBS
containing 10% (vol/vol) fetal calf serum (FCS). Monospeciﬁc mouse pAbs (dilution 1:100) against CyHV-3
ORF148 or ORF149 were used as the primary antibody, followed by Alexa Fluor 568 goat anti-mouse
immunoglobulin G(HL) (Invitrogen) as the secondary antibody (1:1,000 dilution). After a washing step,
the cells were mounted by using Prolong Gold antifade reagent with DAPI (4=,6=-diamidino-2-phenylin-
dole; Invitrogen). Samples were analyzed by confocal microscopy using a Leica SP5 confocal microscope
(14).
Multistep growth curves. Triplicate cultures of CCB cells were infected with CyHV-3 viruses at an
MOI of 0.05 PFU/cell. After incubation for 2 h, the cells were washed with PBS and overlaid with Dulbecco
modiﬁed Eagle medium (DMEM) containing 4.5 g/liter glucose and 10% (vol/vol) FCS. The supernatant
was removed from the infected cultures at successive intervals (2, 4, and 6 dpi) and stored at 80°C.
Titers of infectious viral particles were determined by duplicate plaque assays in CCB cells (24).
Plaque size assay. CCB cells grown in 6-well plates were infected with viruses at an MOI of 200
PFU/well. After incubation for 2 h, the cells were overlaid with DMEM containing 10% (vol/vol) FCS and
0.6% (wt/vol) carboxymethyl cellulose (medium viscosity; Sigma) in order to obtain isolated plaques (25).
TABLE 3 (Continued)
Analysis Primer Sequence (5=–3=)b
Coordinates or
accession no.
ORF115 ORF115.SB-F CTACGCCAACGACGAACC 209426–209443
ORF115.SB-R AGCACCACGAACCACACTC 209776–209758
ORF131 ORF131.SB-F ACTGGAGCGGGTGATAGTTG 225487–225506
ORF131.SB-R GGACTCGTCGTGCCTCTC 225937–225920
PCR
ORF25 ORF25int_F ATCAAGCGCTACGACGACTT 45948–45967
ORF25int_R TGTTGCAGGAGGTGTAGACG 46442–46461
ORF64 ORF64int_F CCATAGTCCAGGACGACGAT 121431–121450
ORF64int_R TGCTGCTTGATGTTCTCCAC 121919–121938
ORF65 ORF65int_F GATGGTCATGTTGGTGTTGC 122996–123015
ORF65int_R CCAAGAACGAGCTCTTCACC 123494–123513
ORF108 ORF108int_F ACCAACTACACGACCGTCTC 201246–201265
ORF108int_R CCGGGTTGGTGTAGGTAGAA 201677–201696
ORF132 ORF132int_F TTGGTTTTTGTTGGTGACGA 227468–227487
ORF132int_R TGACGGGTTCCAAGATTAGC 227936–227955
ORF136 ORF136int_F CTGGTTACATGGGTGGCTTT 231360–231379
ORF136int_R TAGCCCCTGTTGTAGGATGC 231738–231757
ORF148 Pr148fw2 GGTTGTTGGAGTAGTGGTGC 254196–254215
Pr148rev2 CTCATTCAGGCTCGGAGAC 254592–254610
ORF149 Pr149fw1 GTAGTCGCTGGATGTGACG 256662–256680
Pr149rev1 GTCAACACGGACTGCTCCG 257093–257111
ORF112 ORF112intFW CCAGTGTCATCACCACAAGC 205336–205355
ORF112intREV ACGGACATCCTGGGTATCAA 205571–205590
qPCR
CyHV-3 ORF89 KHV-86F GACGCCGGAGACCTTGTG AF411803
KHV-163R CGGGTTCTTATTTTTGTCCTTGTT
KHV-109P (6FAM) CTTCCTCTGCTCGGCGAGCACG (BHQ1)
Carp glucokinase CgGluc-162F ACTGCGAGTGGAGACACATGAT AF053332
CgGluc-230R TCAGGTGTGGAGCGGACAT
CgGluc-185P (6FAM) AAGCCAGTGTCAAAATGCTGCCCACT (BHQ1)
aCoordinates are listed in relation to GenBank accession number NC_009127.1.
bUnderlined: segments correspond to the CyHV-3 sequence; italicization indicates sequences corresponding to galK sequence. Mutated nucleotides are both
underlined and italicized.
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At successive intervals after infection, the plaques were ﬁxed in PBS containing 4% (wt/vol) paraformal-
dehyde at 4°C for 15 min and then 20°C for 10 min. Images were captured with a confocal microscope
(Nikon A1R). For each virus, 25 plaques were measured in duplicate wells. The plaque area was measured
by using ImageJ 1.46 software (26).
Fish. Common carp (Cyprinus carpio) were kept in 60-liter tanks at 24°C. Water parameters were
checked twice per week. The health of the ﬁsh was conﬁrmed by microbiological, parasitic, and clinical
examination immediately prior to the experiments, all of which were preceded by an acclimation period
of at least 2 weeks.
Inoculation of ﬁsh with CyHV-3. Two modes of inoculation were used: immersion in infectious
water and cohabitation with newly infected ﬁsh. For inoculation by immersion, the ﬁsh were immersed
for 2 h in constantly aerated water containing virus, the volume of water being adjusted to a biomass
of around 10% on the basis of ﬁsh size and number. At the end of the incubation period, the ﬁsh were
returned to 60-liter tanks. For inoculation by cohabitation, naive ﬁsh were immersed for 2 h in water
containing 400 PFU/ml of the FL or M3 strain of CyHV-3. The newly infected ﬁsh were then released into
tanks at a ratio of 2 newly infected ﬁsh per 20 ﬁsh to be infected.
Ethics statement. The maintenance and care of ﬁsh and the experiments conducted complied with
the guidelines of the European Convention for the Protection of Vertebrate Animals Used for Experimental
and other Scientiﬁc Purposes (CETS 123). The animal studies were approved by the local ethics committee
of the University of Liège, Belgium (laboratory accreditation 1610008, protocol 1414). All efforts were
made to minimize suffering.
Quantiﬁcation of virus genome copies in organs by real-time TaqMan PCR. The virus genome
was quantiﬁed by real-time TaqMan PCR as described previously (24), by amplifying fragments of the
CyHV-3 ORF89 and carp glucokinase genes. The primers and probes are listed in Table 3.
Statistical analysis. Viral growth (Fig. 5A) and plaque size (Fig. 5B) results were compared by using
two-way analysis of variance (ANOVA) with interactions, followed by a post hoc Student t test. qPCR
results (Fig. 9) were compared using one-way ANOVA, followed by a post hoc Student t test. Survival
curves (Fig. 6 and 10) were compared by using log-rank tests. These analyses were done by using
GraphPad Prism 5. The variables used and comparisons retained for statistical illustrations are presented
in the ﬁgure legends. Statistical signiﬁcance is represented in the ﬁgures by asterisks as follows: *, P 
0.05; **, P  0.01; and ***, P  0.001.
ACKNOWLEDGMENTS
C.V. is a research fellow of the Fonds National Belge de la Recherche Scientiﬁque
(FNRS). This study was supported by the University of Liège (ARC15/19-12), the Belgian
Science Policy (Belspo) (BELVIR IAP7/45), the FNRS (grant 2877824), and the Medical
Research Council (MC_UU_12014/3).
We are grateful to Cédric Delforge, Emeline Deglaire, Aurélie Vanderlinden, Justine
Javaux, and Lorène Dams for excellent technical assistance. We are grateful to S.
Bergman, M. Kotler, F. Lieffrig, and K. Way for providing CyHV-3 strains.
REFERENCES
1. Food and Agriculture Organization of the United Nations. 2015. Global
aquaculture production, 1950–2013. FAO, Rome, Italy. http://www.fao
.org/ﬁshery/statistics/global-aquaculture-production/query/fr/en/.
2. Ilouze M, Dishon A, Kotler M. 2006. Characterization of a novel virus
causing a lethal disease in carp and koi. Microbiol Mol Biol Rev
70:147–156. https://doi.org/10.1128/MMBR.70.1.147-156.2006.
3. Rakus KL, Ouyang P, Boutier M, Ronsmans M, Reschner A, Vancsok C,
Jazowiecka-Rakus J, Vanderplasschen A. 2013. Cyprinid herpesvirus 3: an
interesting virus for applied and fundamental research. Vet Res 44:85.
https://doi.org/10.1186/1297-9716-44-85.
4. Boutier M, Ronsmans M, Rakus K, Jazowiecka-Rakus J, Vancsok C, Morvan
L, Peñaranda MMD, Stone DM, Way K, van Beurden SJ, Davison AJ,
Vanderplasschen A. 2015. Cyprinid herpesvirus 3: an archetype of ﬁsh
alloherpesviruses. Adv Virus Res 93:161–256. https://doi.org/10.1016/bs
.aivir.2015.03.001.
5. Aoki T, Hirono I, Kurokawa K, Fukuda H, Nahary R, Eldar A, Davison AJ,
Waltzek TB, Bercovier H, Hedrick RP. 2007. Genome sequences of three
koi herpesvirus isolates representing the expanding distribution of an
emerging disease threatening koi and common carp worldwide. J Virol
81:5058–5065. https://doi.org/10.1128/JVI.00146-07.
6. Davison AJ, Kurobe T, Gatherer D, Cunningham C, Korf I, Fukuda H,
Hedrick RP, Waltzek TB. 2013. Comparative genomics of carp herpesvi-
ruses. J Virol 87:2908–2922. https://doi.org/10.1128/JVI.03206-12.
7. Waltzek TB, Kelley GO, Stone DM, Way K, Hanson L, Fukuda H, Hirono I,
Aoki T, Davison AJ, Hedrick RP. 2005. Koi herpesvirus represents a third
cyprinid herpesvirus (CyHV-3) in the family Herpesviridae. J Gen Virol
86:1659–1667. https://doi.org/10.1099/vir.0.80982-0.
8. Miyazaki T, Kuzuya Y, Yasumoto S, Yasuda M, Kobayashi T. 2008. Histo-
pathological and ultrastructural features of Koi herpesvirus (KHV)-
infected carp Cyprinus carpio, and the morphology and morphogenesis
of KHV. Dis Aquat Organ 80:1–11. https://doi.org/10.3354/dao01929.
9. Michel B, Leroy B, Stalin Raj V, Lieffrig F, Mast J, Wattiez R, Vanderplass-
chen AF, Costes B. 2010. The genome of cyprinid herpesvirus 3 encodes
40 proteins incorporated in mature virions. J Gen Virol 91:452–462.
https://doi.org/10.1099/vir.0.015198-0.
10. Yi Y, Zhang H, Lee X, Weng S, He J, Dong C. 2014. Extracellular virion
proteins of two Chinese CyHV-3/KHV isolates, and identiﬁcation of two
novel envelope proteins. Virus Res 191:108–116. https://doi.org/10
.1016/j.virusres.2014.07.034.
11. Lete C, Palmeira L, Leroy B, Mast J, Machiels B, Wattiez R, Vanderplass-
chen A, Gillet L. 2012. Proteomic characterization of bovine herpesvirus
4 extracellular virions. J Virol 86:11567–11580. https://doi.org/10.1128/
JVI.00456-12.
12. van Beurden SJ, Leroy B, Wattiez R, Haenen OL, Boeren S, Vervoort JJ,
Peeters BP, Rottier PJ, Engelsma MY, Vanderplasschen AF. 2011. Identi-
ﬁcation and localization of the structural proteins of anguillid herpesvi-
rus 1. Vet Res 42:105. https://doi.org/10.1186/1297-9716-42-105.
13. Vidick S, Leroy B, Palmeira L, Machiels B, Mast J, François S, Wattiez R,
Vanderplasschen A, Gillet L. 2013. Proteomic characterization of murid
herpesvirus 4 extracellular virions. PLoS One 8:e83842. https://doi.org/
10.1371/journal.pone.0083842.
14. Costes B, Fournier G, Michel B, Delforge C, Raj VS, Dewals B, Gillet L,
Drion P, Body A, Schynts F, Lieffrig F, Vanderplasschen A. 2008. Cloning
of the koi herpesvirus genome as an infectious bacterial artiﬁcial chro-
CyHV-3 Virion Transmembrane Proteins Journal of Virology
November 2017 Volume 91 Issue 21 e01209-17 jvi.asm.org 19
 o
n
 O
ctober 25, 2017 by SW
ETS SUBSCRIPTIO
N SERVICE
http://jvi.asm.org/
D
ow
nloaded from
 
mosome demonstrates that disruption of the thymidine kinase locus
induces partial attenuation in Cyprinus carpio koi. J Virol 82:4955–4964.
https://doi.org/10.1128/JVI.00211-08.
15. Boutier M, Ronsmans M, Ouyang P, Fournier G, Reschner A, Rakus K,
Wilkie GS, Farnir F, Bayrou C, Lieffrig F, Li H, Desmecht D, Davison AJ,
Vanderplasschen A. 2015. Rational development of an attenuated re-
combinant cyprinid herpesvirus 3 vaccine using prokaryotic mutagene-
sis and in vivo bioluminescent imaging. PLoS Pathog 11:e1004690.
https://doi.org/10.1371/journal.ppat.1004690.
16. Neukirch M, Böttcher K, Bunnajrakul S. 1999. Isolation of a virus from koi
with altered gills. Bull Eur Assoc Fish Pathol 19:221–224.
17. Torrent F, Villena A, Lee PA, Fuchs W, Bergmann SM, Coll JM. 2016. The
amino-terminal domain of ORF149 of koi herpesvirus is preferentially
targeted by IgM from carp populations surviving infection. Arch Virol
161:2653–2665. https://doi.org/10.1007/s00705-016-2934-4.
18. Li W, Lee X, Weng S, He J, Dong C. 2015. Whole-genome sequence of a
novel Chinese cyprinid herpesvirus 3 isolate reveals the existence of a
distinct European genotype in East Asia. Vet Microbiol 175:185–194.
https://doi.org/10.1016/j.vetmic.2014.11.022.
19. Ronen A, Perelberg A, Abramowitz J, Hutoran M, Tinman S, Bejerano I,
Steinitz M, Kotler M. 2003. Efﬁcient vaccine against the virus causing a
lethal disease in cultured Cyprinus carpio. Vaccine 21:4677–4684. https://
doi.org/10.1016/S0264-410X(03)00523-1.
20. Costes B, Raj VS, Michel B, Fournier G, Thirion M, Gillet L, Mast J, Lieffrig
F, Bremont M, Vanderplasschen A. 2009. The major portal of entry of koi
herpesvirus in Cyprinus carpio is the skin. J Virol 83:2819–2830. https://
doi.org/10.1128/JVI.02305-08.
21. Leroy B, Roupie V, Noel-Georis I, Rosseels V, Walravens K, Govaerts M,
Huygen K, Wattiez R. 2007. Antigen discovery: a postgenomic approach
to paratuberculosis diagnosis. Proteomics 7:1164–1176. https://doi.org/
10.1002/pmic.200600988.
22. Ishihama Y, Oda Y, Tabata T, Sato T, Nagasu T, Rappsilber J, Mann M.
2005. Exponentially modiﬁed protein abundance index (emPAI) for es-
timation of absolute protein amount in proteomics by the number of
sequenced peptides per protein. Mol Cell Proteomics 4:1265–1272.
https://doi.org/10.1074/mcp.M500061-MCP200.
23. Rakus K, Ronsmans M, Forlenza M, Boutier M, Piazzon MC, Jazowiecka-
Rakus J, Gatherer D, Athanasiadis A, Farnir F, Davison AJ, Boudinot P,
Michiels T, Wiegertjes GF, Vanderplasschen A. 2017. Conserved fever
pathways across vertebrates: a herpesvirus expressed decoy TNF- re-
ceptor delays behavioral fever in ﬁsh. Cell Host Microbe 21:244–253.
https://doi.org/10.1016/j.chom.2017.01.010.
24. Ouyang P, Rakus K, Boutier M, Reschner A, Leroy B, Ronsmans M, Fournier
G, Scohy S, Costes B, Wattiez R, Vanderplasschen A. 2013. The IL-10 homo-
logue encoded by cyprinid herpesvirus 3 is essential neither for viral repli-
cation in vitro nor for virulence in vivo. Vet Res 44:53. https://doi.org/10
.1186/1297-9716-44-53.
25. Vanderplasschen A, Bublot M, Dubuisson J, Pastoret P-P, Thiry E. 1993.
Attachment of the gammaherpesvirus bovine herpesvirus 4 is mediated
by the interaction of gp8 glycoprotein with heparinlike moieties on the
cell surface. Virology 196:232–240. https://doi.org/10.1006/viro.1993
.1471.
26. Abràmoff MD, Magalhães PJ, Ram SJ. 2004. Image processing with
ImageJ. Biophotonics Int 11:36–42.
Vancsok et al. Journal of Virology
November 2017 Volume 91 Issue 21 e01209-17 jvi.asm.org 20
 o
n
 O
ctober 25, 2017 by SW
ETS SUBSCRIPTIO
N SERVICE
http://jvi.asm.org/
D
ow
nloaded from
 
